Recipe for ABEL and adjusted α [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2017-03-23 20:10 (2885 d 09:11 ago) – Posting: # 17181
Views: 5,304

Dear all,

since we published our paper1 about the Type I Error, I received questions about its application, regulatory acceptability, etc. In the following I summarize my answers.Answers to questions not asked:@Detlew: Something wrong or did I forget anything?


  1. Labes D, Schütz H. Inflation of Type I Error in the Evaluation of Scaled Average Bioequivalence, and a Method for its Control. Pharm Res. 2016;33(11):2805–14. doi:10.1007/s11095-016-2006-1. [image] free full-text view-only.
  2. Zheng C, Wang J, Zhao L. Testing bioequivalence for multiple formulations with power and sample size calculations. Pharm Stat. 2012;11(4):334–41. doi:10.1002/pst.1522


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,665 registered users;
83 visitors (0 registered, 83 guests [including 14 identified bots]).
Forum time: 05:21 CET (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5